Skip to content
★ Sign in to follow
פב

פסיירקס ביו-טק Stock: price and insider trades · Israel

פסיירקס ביו-טק: what insiders have been doing

Every trade that managers of פסיירקס ביו-טק disclose to TASE (ISA) is tracked on this page. From 8 November 2025 to 8 November 2026, the disclosure feed for פסיירקס ביו-טק logged 19 filings by 7 insiders.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

Compared with its exchange (532 companies, median 14 filings), a count of 19 filings is above the norm.

Over the last twelve months, not one insider purchase of פסיירקס ביו-טק stock was filed.

Every figure here comes from the filings published by TASE (ISA) and describes the past, not future prices; it is not investment advice.

Insider Decl.
19
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Financial data

· cache

Last declaration on 7 November 2026
Declarations19 total
  • ●
    Substantial ShareholderExecutives
    0TASE
    2,286,282 sharesShareXTAETASE:1911:12005:1176908:2026-11-03
  • ●
    Substantial ShareholderExecutives
    0TASE
    2,250,032 sharesShareXTAETASE:1911:12005:1176908:2026-10-22
  • ●
    Substantial ShareholderExecutives
    0TASE
    2,202,494 sharesShareXTAETASE:1911:12005:1176908:2026-10-21
  • ●
    Executives
    10TASE
    825,574 shares100.0% of flowShareXTAETASE:1911:14063:1176908:2026-02-23
  • ●
    Executives
    0TASE
    1,661,010 sharesShareXTAETASE:1911:12005:1219427:2026-04-19
  • ●
    Executives
    10TASE
    2,190,494 shares100.0% of flowShareXTAETASE:1911:12005:1176908:2026-04-19
  • ●
    Executives
    0TASE
    282,585 sharesShareXTAETASE:1911:14213:1239797:2026-04-19
  • ●
    Executives
    10TASE
    590,102 shares100.0% of flowShareXTAETASE:1911:12612:1176908:2025-11-27
  • ●
    Executives
    10TASE
    636,130 shares100.0% of flowShareXTAETASE:1911:11355:1176908:2025-11-27
  • ●
    Executives
    0TASE
    1,468,755 sharesShareXTAETASE:1911:11355:1232487:2025-11-27
  • ●
    Executives
    0TASE
    95,308 sharesShareXTAETASE:1911:12005:1232487:2026-02-10
  • ●
    Executives
    0TASE
    202,520 sharesShareXTAETASE:1911:12005:1239797:2026-04-19
  • ●
    Executives
    0TASE
    1,362,487 sharesShareXTAETASE:1911:12612:1232487:2025-11-27
  • ●
    Executives
    0TASE
    17,132 sharesShareXTAETASE:1911:13799:1176908:2025-06-11
  • ●
    Executives
    0TASE
    546,887 sharesShareXTAETASE:1911:13799:1219427:2025-11-26
  • ●
    Executives
    0TASE
    28,023 sharesShareXTAETASE:1911:14062:1219427:2025-11-27
  • ●
    Executives
    0TASE
    1,906,169 sharesShareXTAETASE:1911:14063:1232487:2026-02-23
  • ●
    Executives
    10TASE
    1,700,000 shares100.0% of flowShareXTAETASE:1911:14213:1176908:2026-04-19
  • ●
    Executives
    0TASE
    997,510 sharesShareXTAETASE:1911:14213:1219427:2026-04-19

19 of 19 declarations

About פסיירקס ביו-טק

Psyrex Biotech is a company operating on the XTAE market, specializing in the biotechnology sector. It focuses on developing innovative solutions in the healthcare field.